Development
Ocular Therapeutix, Inc.
OCUL
$8.29
-$0.04-0.48%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 195.81M | 110.55M | 66.61M | 79.03M | 102.30M |
| Total Receivables | 26.18M | 23.59M | 27.31M | 21.12M | 21.33M |
| Inventory | 2.31M | 2.26M | 2.20M | 2.27M | 1.97M |
| Prepaid Expenses | 7.79M | 4.86M | 4.59M | 4.75M | 4.03M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 150.00K | -- | -- | -- | -- |
| Total Current Assets | 232.24M | 141.26M | 100.71M | 107.16M | 129.63M |
|
|
|||||
| Total Current Assets | 232.24M | 141.26M | 100.71M | 107.16M | 129.63M |
| Net Property, Plant & Equipment | 18.21M | 19.36M | 20.08M | 19.65M | 17.90M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.61M | 1.76M | 1.76M | 1.76M | 1.76M |
| Total Assets | 252.06M | 162.38M | 122.56M | 128.57M | 149.29M |
|
|
|||||
| Total Accounts Payable | 4.39M | 3.98M | 3.57M | 5.44M | 5.12M |
| Total Accrued Expenses | 28.67M | 28.89M | 24.60M | 21.99M | 24.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.59M | 1.88M | 3.80M | 1.82M | 1.60M |
| Total Finance Division Other Current Liabilities | 255.00K | 317.00K | 391.00K | 463.00K | 576.00K |
| Total Other Current Liabilities | 255.00K | 317.00K | 391.00K | 463.00K | 576.00K |
| Total Current Liabilities | 34.90M | 35.07M | 32.36M | 29.72M | 31.40M |
|
|
|||||
| Total Current Liabilities | 34.90M | 35.07M | 32.36M | 29.72M | 31.40M |
| Long-Term Debt | 74.93M | 73.89M | 53.28M | 54.68M | 54.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.88M | 7.25M | 7.69M | 8.11M | 8.68M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 44.23M | 38.33M | 26.14M | 26.35M | 19.83M |
| Total Liabilities | 160.93M | 154.53M | 119.47M | 118.86M | 113.91M |
|
|
|||||
| Common Stock & APIC | 788.71M | 676.21M | 670.93M | 656.87M | 652.22M |
| Retained Earnings | -697.58M | -668.36M | -667.84M | -647.16M | -616.84M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 91.13M | 7.85M | 3.09M | 9.71M | 35.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 91.13M | 7.85M | 3.09M | 9.71M | 35.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 91.13M | 7.85M | 3.09M | 9.71M | 35.38M |
|
|
|||||